Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Hemant Surgical Industries Ltd. shows significant weaknesses in growth, profitability, and valuation metrics compared to its peers in the Medical Equipment/Supplies sector. While its peers demonstrate varying degrees of performance, Poly Medicure Ltd. stands out as a leader in growth and profitability, whereas Nureca Ltd. is flagged as financially weak due to negative earnings and high valuation ratios.
Highest revenue growth (YoY: 21.37%) and strong profitability metrics (ROE: 16.01%).
Solid profitability with ROE of 18.70% and attractive valuation metrics.
High ROE of 96.95%, despite high PE, indicating strong earnings generation.